POTASSIUM CHLORIDE EXTENDED RELEASE

Aphena Pharma Solutions - Tennessee, LLC🇺🇸 United States

FDA Page

Effective Date: Jul 31, 2025
Approval ID: 3b403d60-4246-d765-e063-6394a90a12e8
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948

Quick Stats

Total Products1

Labelers1

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.